- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 39.8M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $964M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $963M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $373M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $484M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $968M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $969M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.21B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.19B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.79B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.84B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.75B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.77B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 46.5M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $12M |
| Capex | Q1 2025 · Mar 31, 2024 | $43M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $31M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.85B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.89B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.62 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.63 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $104M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $27M |
| Net Income | Q1 2025 · Mar 31, 2024 | $29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $71M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $192M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $671M |
| Revenue | Q1 2025 · Mar 31, 2024 | $863M |